These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34041503)

  • 1. A protocol for rapid degradation of endogenous transcription factors in mammalian cells and identification of direct regulatory targets.
    Layden HM; Eleuteri NA; Hiebert SW; Stengel KR
    STAR Protoc; 2021 Jun; 2(2):100530. PubMed ID: 34041503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for establishing inducible CRISPRd system for blocking transcription factor-binding sites in human pluripotent stem cells.
    Matsui S; Shiley JR; Buckley M; Lim HW; Hu YC; Mayhew CN; Iwafuchi M
    STAR Protoc; 2024 Sep; 5(3):103233. PubMed ID: 39133612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells.
    Guarnaccia AD; Weissmiller AM; Tansey WP
    STAR Protoc; 2021 Dec; 2(4):101000. PubMed ID: 34917979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational pipeline for designing guide RNAs for mismatch-CRISPRi.
    van Gestel J; Hawkins JS; Todor H; Gross CA
    STAR Protoc; 2021 Jun; 2(2):100521. PubMed ID: 34027480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensible combinatorial CRISPR screening in mammalian cells.
    Zhou P; Wan YK; Chan BKC; Choi GCG; Wong ASL
    STAR Protoc; 2021 Mar; 2(1):100255. PubMed ID: 33490975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity.
    Chen YC; Farzadfard F; Gharaei N; Chen WCW; Cao J; Lu TK
    Mol Cell; 2017 Oct; 68(1):247-257.e5. PubMed ID: 28985507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of active Cas7-11 in processing CRISPR RNA and interfering target RNA.
    Goswami HN; Rai J; Das A; Li H
    Elife; 2022 Oct; 11():. PubMed ID: 36190192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for mass spectrometric profiling of lysine malonylation by lysine acetyltransferase in CRISPRi K562 cell lines.
    Zhang R; Bons J; Rose JP; Schilling B; Verdin E
    STAR Protoc; 2024 Jun; 5(2):103074. PubMed ID: 38771695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of auxin inducible degron (AID) knock-in cell lines for targeted protein degradation in mammalian cells.
    Adhikari B; Narain A; Wolf E
    STAR Protoc; 2021 Dec; 2(4):100949. PubMed ID: 34849487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 System.
    Wang Y; Yang LZ; Chen LL
    STAR Protoc; 2020 Jun; 1(1):100037. PubMed ID: 33111085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Testing of CRISPR Nucleases and Guide RNAs in an
    Marshall R; Beisel CL; Noireaux V
    STAR Protoc; 2020 Jun; 1(1):100003. PubMed ID: 33111065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized flow-cytometry-based protocol to simultaneously measure transcription factor levels.
    Manso BA; Medina KL
    STAR Protoc; 2021 Jun; 2(2):100485. PubMed ID: 34041499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish.
    Amorim JP; Bordeira-Carriço R; Gali-Macedo A; Perrod C; Bessa J
    STAR Protoc; 2020 Dec; 1(3):100208. PubMed ID: 33377102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of single guide RNA transcription for efficient CRISPR/Cas-based genomic engineering.
    Ui-Tei K; Maruyama S; Nakano Y
    Genome; 2017 Jun; 60(6):537-545. PubMed ID: 28177825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas type II-based Synthetic Biology applications in eukaryotic cells.
    RNA Biol; ; . PubMed ID: 28136159
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.